PrizValve® Transcatheter Aortic Valve Replacement Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT04836897

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04836897
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04836897. Allocation not applicable; no masking; primary purpose treatment. Start 2021-01-19 (actual); primary completion 2023-06-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PrizValve® Transcatheter Aortic Valve Replacement Study
Condition
Aortic Valve Stenosis
Intervention (Device)
PrizValve® valve and transapical delivery system
Lead sponsor
Shanghai NewMed Medical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04836897
Content hash
049752905b73c723e1770e498c965d1bd0bca5538cd237abed499423522a8807